Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?

Roy L, Cowden Dahl KD.

Cancers (Basel). 2018 Jul 24;10(8). pii: E241. doi: 10.3390/cancers10080241. Review.

2.

CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche.

Roy L, Bobbs A, Sattler R, Kurkewich JL, Dausinas PB, Nallathamby P, Cowden Dahl KD.

Cancer Growth Metastasis. 2018 Apr 9;11:1179064418767882. doi: 10.1177/1179064418767882. eCollection 2018.

3.

Arid3b Is Critical for B Lymphocyte Development.

Kurkewich JL, Klopfenstein N, Hallas WM, Wood C, Sattler RA, Das C, Tucker H, Dahl R, Cowden Dahl KD.

PLoS One. 2016 Aug 18;11(8):e0161468. doi: 10.1371/journal.pone.0161468. eCollection 2016.

4.

Emerging and Evolving Ovarian Cancer Animal Models.

Bobbs AS, Cole JM, Cowden Dahl KD.

Cancer Growth Metastasis. 2015 Aug 12;8(Suppl 1):29-36. doi: 10.4137/CGM.S21221. eCollection 2015. Review.

5.

ARID3B Directly Regulates Ovarian Cancer Promoting Genes.

Bobbs A, Gellerman K, Hallas WM, Joseph S, Yang C, Kurkewich J, Cowden Dahl KD.

PLoS One. 2015 Jun 29;10(6):e0131961. doi: 10.1371/journal.pone.0131961. eCollection 2015.

6.

In vivo tumor growth of high-grade serous ovarian cancer cell lines.

Mitra AK, Davis DA, Tomar S, Roy L, Gurler H, Xie J, Lantvit DD, Cardenas H, Fang F, Liu Y, Loughran E, Yang J, Sharon Stack M, Emerson RE, Cowden Dahl KD, V Barbolina M, Nephew KP, Matei D, Burdette JE.

Gynecol Oncol. 2015 Aug;138(2):372-7. doi: 10.1016/j.ygyno.2015.05.040. Epub 2015 Jun 5.

7.

ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature.

Roy L, Samyesudhas SJ, Carrasco M, Li J, Joseph S, Dahl R, Cowden Dahl KD.

Oncotarget. 2014 Sep 30;5(18):8355-66.

8.

Enrichment for chemoresistant ovarian cancer stem cells from human cell lines.

Cole JM, Joseph S, Sudhahar CG, Cowden Dahl KD.

J Vis Exp. 2014 Sep 10;(91):51891. doi: 10.3791/51891.

9.

Differential expression of ARID3B in normal adult tissue and carcinomas.

Samyesudhas SJ, Roy L, Cowden Dahl KD.

Gene. 2014 Jun 10;543(1):174-80. doi: 10.1016/j.gene.2014.04.007. Epub 2014 Apr 3.

PMID:
24704276
10.

ARID3B induces tumor necrosis factor alpha mediated apoptosis while a novel ARID3B splice form does not induce cell death.

Joseph S, Deneke VE, Cowden Dahl KD.

PLoS One. 2012;7(7):e42159. doi: 10.1371/journal.pone.0042159. Epub 2012 Jul 31.

11.

The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.

Cowden Dahl KD, Dahl R, Kruichak JN, Hudson LG.

Neoplasia. 2009 Nov;11(11):1208-15.

12.

Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.

Cowden Dahl KD, Symowicz J, Ning Y, Gutierrez E, Fishman DA, Adley BP, Stack MS, Hudson LG.

Cancer Res. 2008 Jun 15;68(12):4606-13. doi: 10.1158/0008-5472.CAN-07-5046.

13.
14.

Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation.

Cowden Dahl KD, Fryer BH, Mack FA, Compernolle V, Maltepe E, Adelman DM, Carmeliet P, Simon MC.

Mol Cell Biol. 2005 Dec;25(23):10479-91.

15.

Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression.

Cowden Dahl KD, Robertson SE, Weaver VM, Simon MC.

Mol Biol Cell. 2005 Apr;16(4):1901-12. Epub 2005 Feb 2.

Supplemental Content

Loading ...
Support Center